Trump Administration Approves $2.8 Billion Bomb Sale to Israel Amid Ongoing Gaza Conflict

The Trump administration has finalized plans to transfer $2.8 billion worth of powerful munitions to Israel, including 40,000 destructive 2,000-pound bombs that were previously withheld by the Biden administration due to concerns about civilian casualties in Gaza. According to multiple U.S. officials speaking anonymously, the weapons package contains 20,000 Mk84 bombs and 20,000 BLU-117 bombs, with the majority funded through U.S. foreign military financing programs that essentially subsidize Israel's purchase of American weapons.

Military Capabilities and Humanitarian Concerns

The 2,000-pound bombs included in this transfer represent some of the most devastating conventional weapons in modern arsenals. These munitions exist in multiple variants, with some designed to penetrate deep underground targets like Hamas' tunnel networks while others detonate above ground to cause widespread destruction across surface areas. Weapons experts examining blast patterns and fragmentation evidence in Gaza have confirmed the use of similar U.S.-manufactured bombs during previous Israeli operations, often in densely populated urban environments where collateral damage is inevitable.

The Biden administration had paused delivery of these bombs two years ago specifically due to concerns about their potential to cause mass casualties in Gaza's crowded neighborhoods. Their reintroduction into the conflict zone comes as Gaza's Health Ministry reports over 73,264 Palestinian deaths since Israel's offensive began, with casualties continuing even after the October 2027 ceasefire.

Recent History of U.S. Arms Transfers

This proposed sale continues a pattern of accelerated military support under the Trump administration. In 2024, the Biden administration had placed a temporary hold on one shipment of these bombs, a decision that was reversed when Trump returned to office. Last year, the administration bypassed standard congressional review procedures to approve a $3 billion weapons package containing over 35,500 similar bombs.

That was followed by a January 2027 authorization of $6.67 billion in additional arms sales to Israel, demonstrating a consistent policy of military reinforcement despite ongoing hostilities. These successive transfers have significantly expanded Israel's stockpile of heavy munitions during a period of intense conflict.

Strategic and Diplomatic Context

The arms deal proceeds amid notable tensions between President Trump and Israeli Prime Minister Benjamin Netanyahu, particularly regarding the joint U.S.-Israel military campaign against Iran that began in February 2027. While Trump has publicly expressed frustration with Netanyahu at various points, including before their July 2027 White House meeting, the administration's military support has remained steadfast.

The timing of this sale also coincides with Israel's increasing diplomatic isolation over its conduct in Gaza, raising questions about the political calculus behind the transfer. The Washington Post first reported on the package as Israel faces growing international criticism for its military actions in response to Hamas' October 2023 attacks that killed 1,200 Israelis.

Current Situation in Gaza

Gaza's Health Ministry reports that over 73,264 Palestinians have been killed since Israel launched its offensive in response to Hamas' October 2023 attacks that left 1,200 Israelis dead. Although the most intense fighting subsided after a fragile ceasefire took effect in October 2027, Israeli strikes have continued, including several this week that resulted in additional casualties.

Recent efforts by Jared Kushner, Trump's son-in-law and key Middle East advisor, to reinforce the ceasefire and encourage Israel to scale back attacks have yielded limited results as militants continue targeting Israeli forces. Israel maintains that its ongoing strikes represent responses to ceasefire violations by Hamas and other militant groups.

Congressional and Financial Mechanisms

The administration has begun informal congressional notifications about the pending deal, utilizing foreign military financing structures where U.S. taxpayer dollars are allocated to Israel specifically for purchasing American weaponry. This financing mechanism has drawn increasing scrutiny given the scale of recent arms transfers and concerns about oversight.

The previous $3 billion sale approved in 2026 notably circumvented standard congressional review processes, establishing a precedent that may apply to this current transfer. Congressional sources indicate they have received preliminary notification but await full details of the proposed package.

Military Impact and Strategic Considerations

Analysts suggest the new weapons will primarily target Hamas' extensive underground infrastructure, though the bombs' destructive power raises persistent concerns about civilian harm in Gaza's crowded urban environments. The Israeli military has provided minimal details about its specific munitions usage in Gaza, but open-source investigations have consistently linked U.S.-supplied bombs to major incidents throughout the conflict.

The transfer could significantly enhance Israel's ability to conduct deep-strike operations while potentially prolonging the military campaign. Military experts note the 2,000-pound bombs are particularly effective against hardened underground targets but create substantial collateral damage when used in populated areas.

International Reaction and Legal Implications

The arms transfer occurs as Israel faces mounting international condemnation for its Gaza campaign, including accusations of disproportionate force use. Some legal experts argue continued U.S. weapons transfers could implicate Washington in potential violations of international humanitarian law, given the documented civilian toll of previous bombings using similar munitions.

The United Nations and various human rights organizations have repeatedly called for arms embargoes against Israel during the conflict, making this transfer particularly controversial on the global stage. European allies have expressed particular concern about the potential for these weapons to exacerbate civilian suffering in Gaza.

Future Implications for U.S. Policy

This arms sale demonstrates the Trump administration's prioritization of military partnership with Israel despite humanitarian concerns and strained bilateral relations. The decision to provide bombs previously restricted over civilian protection considerations may further complicate ceasefire negotiations and postwar reconstruction efforts.

As international criticism of Israel's Gaza campaign mounts, the transfer risks reinforcing perceptions of U.S. complicity in the conflict's civilian toll while potentially exacerbating Israel's diplomatic isolation. The move also tests the limits of executive authority in arms transfers and raises questions about congressional oversight of foreign military financing programs that have facilitated billions in weapons sales during the conflict.